ZA9810116B - 1'-4(4-(1-(4-fluorophenyl)-1H-indole-3-yl)-1-butyl)-spiro (isobenzofuran-1(3H),4'-piperidine)hydrohalogenides - Google Patents

1'-4(4-(1-(4-fluorophenyl)-1H-indole-3-yl)-1-butyl)-spiro (isobenzofuran-1(3H),4'-piperidine)hydrohalogenides

Info

Publication number
ZA9810116B
ZA9810116B ZA9810116A ZA9810116A ZA9810116B ZA 9810116 B ZA9810116 B ZA 9810116B ZA 9810116 A ZA9810116 A ZA 9810116A ZA 9810116 A ZA9810116 A ZA 9810116A ZA 9810116 B ZA9810116 B ZA 9810116B
Authority
ZA
South Africa
Prior art keywords
hydrohalogenides
isobenzofuran
spiro
fluorophenyl
indole
Prior art date
Application number
ZA9810116A
Other languages
English (en)
Inventor
Niels Mork
Heidi Lopez De Diego
Ole Nielsen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of ZA9810116B publication Critical patent/ZA9810116B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA9810116A 1997-11-07 1998-11-05 1'-4(4-(1-(4-fluorophenyl)-1H-indole-3-yl)-1-butyl)-spiro (isobenzofuran-1(3H),4'-piperidine)hydrohalogenides ZA9810116B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK126797 1997-11-07

Publications (1)

Publication Number Publication Date
ZA9810116B true ZA9810116B (en) 1999-05-07

Family

ID=8102935

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9810116A ZA9810116B (en) 1997-11-07 1998-11-05 1'-4(4-(1-(4-fluorophenyl)-1H-indole-3-yl)-1-butyl)-spiro (isobenzofuran-1(3H),4'-piperidine)hydrohalogenides

Country Status (39)

Country Link
US (2) US6844352B2 (ko)
EP (1) EP1044202B1 (ko)
JP (1) JP3605358B2 (ko)
KR (1) KR100399274B1 (ko)
CN (1) CN1105115C (ko)
AR (1) AR023010A1 (ko)
AT (1) ATE288918T1 (ko)
AU (1) AU749094B2 (ko)
BG (1) BG64906B1 (ko)
BR (1) BR9813949A (ko)
CA (1) CA2308745C (ko)
CZ (1) CZ288666B6 (ko)
DE (1) DE69828999T2 (ko)
DZ (1) DZ2642A1 (ko)
EA (1) EA002092B1 (ko)
EG (1) EG23791A (ko)
ES (1) ES2234162T3 (ko)
HK (1) HK1034075A1 (ko)
HR (1) HRP20000261B1 (ko)
HU (1) HUP0100991A3 (ko)
ID (1) ID25776A (ko)
IL (1) IL135723A (ko)
IS (1) IS2342B (ko)
JO (1) JO2052B1 (ko)
MA (1) MA25585A1 (ko)
NO (1) NO325920B1 (ko)
NZ (1) NZ504065A (ko)
PE (1) PE130299A1 (ko)
PL (1) PL190538B1 (ko)
PT (1) PT1044202E (ko)
RS (1) RS49777B (ko)
SK (1) SK285245B6 (ko)
TN (1) TNSN98201A1 (ko)
TR (1) TR200001267T2 (ko)
TW (1) TW483894B (ko)
UA (1) UA64769C2 (ko)
UY (1) UY25236A1 (ko)
WO (1) WO1999024436A1 (ko)
ZA (1) ZA9810116B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030453A1 (es) * 2000-08-15 2003-08-20 Lundbeck & Co As H Composicion farmaceutica con contenido de 1' [4-[1-(4-fluorofenil)-1h-indol-3-il]-1-butil] espiro [isobenzofuran-1 (3h), 4'-piperidina]
AU2003263155A1 (en) * 2002-09-20 2004-04-08 H. Lundbeck A/S Method for manufacture of dihydroisobenzofuran derivatives
WO2004110388A2 (en) * 2003-06-12 2004-12-23 Agy Therapeutics, Inc. Sigma ligands for neuronal regeneration and functional recovery
US20090306341A1 (en) * 2005-07-29 2009-12-10 Joachim Emmert LC/MS Blends Containing Ionizing Additives
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP1991212A1 (en) * 2006-03-08 2008-11-19 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
EP2026813A2 (en) * 2006-05-09 2009-02-25 Braincells, Inc. 5 ht receptor mediated neurogenesis
BRPI0716604A2 (pt) * 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080103165A1 (en) * 2006-09-19 2008-05-01 Braincells, Inc. Ppar mediated modulation of neurogenesis
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
MA25585A1 (fr) 2002-12-31
EG23791A (en) 2007-08-13
KR20010031791A (ko) 2001-04-16
NO325920B1 (no) 2008-08-18
EP1044202A1 (en) 2000-10-18
PT1044202E (pt) 2005-04-29
HRP20000261A2 (en) 2001-04-30
DZ2642A1 (fr) 2004-12-28
ATE288918T1 (de) 2005-02-15
DE69828999T2 (de) 2005-07-21
US20030055074A1 (en) 2003-03-20
EP1044202B1 (en) 2005-02-09
BG64906B1 (bg) 2006-08-31
NO20002188L (no) 2000-06-14
PE130299A1 (es) 1999-12-16
BR9813949A (pt) 2000-09-26
CN1278823A (zh) 2001-01-03
US20050171135A1 (en) 2005-08-04
CA2308745C (en) 2004-01-20
CN1105115C (zh) 2003-04-09
DE69828999D1 (de) 2005-03-17
JO2052B1 (en) 1999-05-15
CA2308745A1 (en) 1999-05-20
PL190538B1 (pl) 2005-12-30
SK285245B6 (sk) 2006-09-07
BG104485A (en) 2001-01-31
HUP0100991A3 (en) 2003-03-28
TW483894B (en) 2002-04-21
IS5460A (is) 2000-04-18
TR200001267T2 (tr) 2000-09-21
EA200000502A1 (ru) 2000-10-30
IL135723A0 (en) 2001-05-20
NO20002188D0 (no) 2000-04-27
AR023010A1 (es) 2002-09-04
SK6462000A3 (en) 2000-10-09
JP2001522852A (ja) 2001-11-20
WO1999024436A1 (en) 1999-05-20
US6844352B2 (en) 2005-01-18
YU23500A (sh) 2003-12-31
HUP0100991A2 (hu) 2001-09-28
CZ288666B6 (cs) 2001-08-15
KR100399274B1 (ko) 2003-09-26
RS49777B (sr) 2008-06-05
NZ504065A (en) 2002-05-31
UA64769C2 (uk) 2004-03-15
HK1034075A1 (en) 2001-10-12
ES2234162T3 (es) 2005-06-16
ID25776A (id) 2000-11-02
AU1022699A (en) 1999-05-31
TNSN98201A1 (fr) 2005-03-15
JP3605358B2 (ja) 2004-12-22
CZ20001663A3 (cs) 2000-10-11
UY25236A1 (es) 2000-12-29
AU749094B2 (en) 2002-06-20
PL340220A1 (en) 2001-01-15
IL135723A (en) 2005-11-20
HRP20000261B1 (en) 2009-04-30
IS2342B (is) 2008-02-15
EA002092B1 (ru) 2001-12-24

Similar Documents

Publication Publication Date Title
ZA9810116B (en) 1'-4(4-(1-(4-fluorophenyl)-1H-indole-3-yl)-1-butyl)-spiro (isobenzofuran-1(3H),4'-piperidine)hydrohalogenides
AU1765695A (en) Non-peptidyl tachykinin receptor antagonists
AU696241B2 (en) Dihydropyridine NPY antagonists: piperazine derivatives
AU5374294A (en) 4-carboxoamido piperidine derivatives, intermediates and use as neurokinin antagonists
AU3128195A (en) Piperidines and hexahydro-1h-azepines spiro substituted at the 4-position promote release of growth hormone
AU3182495A (en) Azetidine, pyrrolidine and piperidine derivatives
AU5417296A (en) Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
AU1474495A (en) Fence adjustment mechanism
ZA952431B (en) New piperidine derivatives
AU4447896A (en) Toilet seat including height increasing apparatus
HK1091806A1 (en) Antihistaminic piperidine derivatives and intermediates for the preparation thereof
DE69629454D1 (en) Antipsychotische 4-(1h-indolyl-1-yl)-1-substituierte piperidine derivate
AU2320895A (en) Polyalkylpiperidine compounds
AU7578496A (en) Azetidine, pyrrolidine and piperidine derivatives
SI1044202T1 (en) 1'- 4- 1- (4-fluorophenyl)- 1h-indole-3-yl) -1-butyl)-spiro isobenzofuran- 1(3h),4'- piperidine) hydrohalogenides
AU4326685A (en) 4-(2-(dialkylamino)ethyl)isatins
AU4089093A (en) Reservoir-type plaster containing ketorolac
AU2001279607A1 (en) Pharmaceutical composition containing 1'-(4-(1-(4-fluorophenyl)-1h-indole-3-yl) -1-butyl)-spiro(isobenzofuran-1(3h),4'-piperidine)
NZ329359A (en) Spiro[2h 1 benzopyran -2,4'-piperidine] derivatives and medicaments thereof
AU5321796A (en) Novel piperazine derivatives as type il-1 receptor antagonists
AU2003268868B8 (en) Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
AU3403593A (en) Improved height adjustment device
HUP9902563A3 (en) Piperidine derivatives, intermediates, preparation and use thereof
SI0853619T1 (en) Disubstituted piperidine derivatives
TW298228U (en) Improved positioning and adjustment structure for shower head